Skip to content

Dose reduction and image quality in low tube voltage CT colonography: evaluation the efficacy of SAFIRE

Dose reduction and image quality in low tube voltage CT colonography: evaluation the efficacy of SAFIRE - SAFIRE CTC study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025762
Enrollment
20
Registered
2017-01-25
Start date
2015-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy individual

Interventions

None listed

Sponsors

Radiology section, NTT East Izu Hospital
Lead Sponsor
National Cancer Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy individual. 2) Major functions of organs of the subjects are in a good condition. 3) Aged 20 years or older.

Exclusion criteria

Exclusion criteria: 1) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon. 2) Evidence of an increased risk in carrying out bowel preparation or CTC exams. 3) Possibility of pregnancy. 4) Patients with psychological conditions that contraindicate CT colonography or make them irrelevant to participate in the trial. 5) Claustrophobia. 6) Iodine hypersensitivity. 7) Severe thyroid disease. 8) Severe deafness. 9) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.

Design outcomes

Primary

MeasureTime frame
Image quality and noise assessments for CT colonography with iterative reconstruction (SAFIRE).

Countries

Japan

Contacts

Public ContactShogo Takiguchi

NTT East Izu Hospital Radiology section

syogo@east.ntt.co.jp+81-55-978-2320

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026